These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36974517)

  • 1. SUMO1 hinders α-Synuclein fibrillation by inducing structural compaction.
    Panigrahi R; Krishnan R; Singh JS; Padinhateeri R; Kumar A
    Protein Sci; 2023 May; 32(5):e4632. PubMed ID: 36974517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation.
    Liang Z; Chan HYE; Lee MM; Chan MK
    Cell Chem Biol; 2021 Feb; 28(2):180-190.e6. PubMed ID: 33444530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein.
    Dorval V; Fraser PE
    J Biol Chem; 2006 Apr; 281(15):9919-24. PubMed ID: 16464864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein.
    Williams JK; Yang X; Baum J
    Proteomics; 2018 Nov; 18(21-22):e1800109. PubMed ID: 30142698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
    Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
    J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of inhibition of α-synuclein aggregation in vitro by SUMOylation is conjugation site- and SUMO isoform-selective.
    Abeywardana T; Pratt MR
    Biochemistry; 2015 Feb; 54(4):959-61. PubMed ID: 25607946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Analysis of a Complex between Small Ubiquitin-like Modifier 1 (SUMO1) and the ZZ Domain of CREB-binding Protein (CBP/p300) Reveals a New Interaction Surface on SUMO.
    Diehl C; Akke M; Bekker-Jensen S; Mailand N; Streicher W; Wikström M
    J Biol Chem; 2016 Jun; 291(24):12658-12672. PubMed ID: 27129204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25.
    Meulmeester E; Kunze M; Hsiao HH; Urlaub H; Melchior F
    Mol Cell; 2008 Jun; 30(5):610-9. PubMed ID: 18538659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity.
    Vijayakumaran S; Wong MB; Antony H; Pountney DL
    Biomolecules; 2015 Jul; 5(3):1697-716. PubMed ID: 26213981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.
    Namanja AT; Li YJ; Su Y; Wong S; Lu J; Colson LT; Wu C; Li SS; Chen Y
    J Biol Chem; 2012 Jan; 287(5):3231-40. PubMed ID: 22147707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases.
    Wang W; Matunis MJ
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation.
    Rott R; Szargel R; Shani V; Hamza H; Savyon M; Abd Elghani F; Bandopadhyay R; Engelender S
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13176-13181. PubMed ID: 29180403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO-SIM interactions: From structure to biological functions.
    Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J
    Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of SUMO1-SUMOylome changes during defense elicitation in Arabidopsis.
    Ingole KD; Dahale SK; Bhattacharjee S
    J Proteomics; 2021 Feb; 232():104054. PubMed ID: 33238213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson's Disease Models.
    Verma DK; Ghosh A; Ruggiero L; Cartier E; Janezic E; Williams D; Jung EG; Moore M; Seo JB; Kim YH
    eNeuro; 2020; 7(5):. PubMed ID: 32887693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polyols on the structure and aggregation of recombinant human γ-Synuclein, an intrinsically disordered protein.
    Roy S; Bhat R
    Biochim Biophys Acta Proteins Proteom; 2018 Oct; 1866(10):1029-1042. PubMed ID: 30003969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of high-throughput screening assays and identification of a SUMO1-specific small molecule chemotype targeting the SUMO-interacting motif-binding surface.
    Alontaga AY; Li Y; Chen CH; Ma CT; Malany S; Key DE; Sergienko E; Sun Q; Whipple DA; Matharu DS; Li B; Vega R; Li YJ; Schoenen FJ; Blagg BS; Chung TD; Chen Y
    ACS Comb Sci; 2015 Apr; 17(4):239-46. PubMed ID: 25719760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Role of Ca
    Han JY; Choi TS; Kim HI
    Sci Rep; 2018 Jan; 8(1):1895. PubMed ID: 29382893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.